(1)
Weisshaar, E.; Sciascia, T.; Stander, S. Efficacy and Safety of Oral Nalbuphine Extended Release in Prurigo Nodularis: Results of a Phase 2, Randomized, Controlled Trial With an Open Open-Label Extension Phase. J of Skin 2021, 5, s29.